Automated

Scalable

Accessible

Limula offers a unique technology supporting routine manufacturing of highly-personalised cell therapies. We address one of the biggest challenges in this industry - How to enable the transition from open and manual methods towards closed and automated processes?

Automated

Scalable

Accessible

Limula offers a unique technology supporting routine manufacturing of highly-personalised cell therapies. We address one of the biggest challenges in this industry - How to enable the transition from open and manual methods towards closed and automated processes?

asdfasdf

About Limula

Swiss Made engineering meets cell therapy

Our company is based in Lausanne, Switzerland. We thrive in this world-class ecosystem, tapping into the country’s long tradition of Pharma and Biotech. We have privileged access to exceptional engineering and life science talent and infrastructure, delivering the highest product quality.

Our team

We think out of the box.

We combine decades of experience in different industries to develop a highly innovative and multidisciplinary approach to Cell & Gene Therapy manufacturing.

Leadership

Luc_LIM4557
LUC HENRY
Founder and CEO
Luc graduated from the University of Oxford with a DPhil in Chemical Biology. He has 10 years of research experience and published over 15 peer-reviewed scientific reports in chemistry, biotechnology and immunology. Prior to founding Limula, he was a strategic advisor to the President of EPFL, Martin Vetterli. At Limula, his role is to build meaningful partnerships to maximise the impact of our technology.
Yann_LIM4514
Yann Pierson
Founder and CTO
Yann graduated from EPFL with a PhD in Chemical Biology and is a certified mechanical designer. He invented, patented and built the first prototype of the technology behind our revolutionary CGT manufacturing platform in his garage during the COVID pandemic lock-down. At Limula, his role is to build an innovative product that meets the performance, quality and regulatory needs of our customers.
Tom_LIM4471
Thomas Eaton
Founder and COO
Tom graduated from the University of Basel with a PhD in Material Sciences. Tom has extensive experience in project management, budget tracking, outsourcing and supplier oversight. He has worked for, and consulted to, multinationals, including Deloitte, UBS and SwissRe as a project facilitator. At Limula, his role is to establish company processes to support our objectives and reach our potential.

Team

Olivier_LIM4570
Olivier Waridel
Head of Product
Olivier is a serial entrepreneur and was the CEO of Biosafe Group SA until 2016 (now part of Cytiva). Under his leadership, the Sepax device became an industry standard for cell processing in biobanks, transplantation centres, hospitals and biopharma. Before joining Limula, he was a consultant for start-up/mid-size life science tools and medical device companies.
Carolina_LIM4235
Caroline Boudousquié
Head of Applications
Caroline graduated from the University of Lausanne with a PhD in Immunology in 2006 and pursued an academic career in onco-immunology before moving to the biotechnology industry. In 2016, Caroline joined the Center for Experimental Therapeutics of the CHUV where she built and led the Process Development team with the mission to develop and transfer GMP compliant cell therapies manufacturing processes from R&D to GMP production.
Shady_LIM3955
Shady Gawad
Head of Digital
Shady earned his PhD in biosensors and microelectronics from EPFL. He is a pioneer in the development of impedance-based sensing technologies for applications in cell biology and immunology. He previously was a Sensor Architect at Léman Micro Devices and a Sensor Designer at Measurement Specialties, Inc (now TE Connectivity).
Maria Elena_LIM4182
Maria Elena GRISOSTOLO
Head of Quality
Maria Elena has a decade of experience in medtech companies including Johnson&Johnson, Medtronic and Lunaphore. As VP of Operations at Lunaphore, she played a critical role in the implementation and execution of quality and regulatory affairs, from the company inception to a successful exit.
William_LIM4062
William Bovy
Product engineer
William earned a BSc in Mechatronics and a MSc in Biomedical Engineering. He spent several years at Debiotech SA, where he developed a strong R&D expertise in medical devices, including a home peritoneal dialysis machine with complex disposable sets. He also has experience in project management and verification activities for FDA approval.
Philippe_LIM4041
Philippe Mazouer
Senior Software Engineer
Philippe started his career at Philips Healthcare in the Netherlands, developing applications for X-Ray and Ultrasound systems. He was then active in the field of cell and gene therapies with Cytiva.
Carolina_LIM3873
Carolina Jiménez Navarro
Biotechnologist
Carolina graduated with a MSc in Biology and Biomedicine at the Universidad de Cantabria, Spain. She has gained experience in cell biology and immunology at the University of Fribourg.
Omran_LIM3868
Omran El Rifaï
Mechatronics Engineer
Omran brings expertise in designing medical devices and laboratory automation systems. He began his carrier at Lambda Health System, a Swiss start-up active in robotic-based rehabilitation of the lower limbs.
Leo_LIM4280
Léo Corsini
Mechatronics Engineer
Léo graduated from HEIG-VD with a BSc degree at the intersection between hardware and software.
Luca_DSC2317-Enhanced-SR_V2
Luca Bellosta
Product Specialist
Luca graduated with a MSc in Bioengineering at Politecnico di Milano, Italy. He gained research experience in immuno-engineering at EPFL, Switzerland.
Sarah_LIM3742
Sarah de la Mota
Business Development intern
Sarah graduated with a MSc from University College London, UK, specialising in the manufacturing and commercialisation of cell and gene therapies. She completed her thesis research at Quell Therapeutics, focusing on the development of cell therapies for immunomodulatory applications.

Advisors

ADVISOR_Denis_Migliorini
Prof. Denis Migliorini
Denis is a practicing physician and Head of Neuro-oncology at the Department of Oncology of the University Hospital of Geneva (HUG), Switzerland. He also leads the Brain Tumour and Immune Cell Engineering Group at the AGORA Cancer Research Center in Lausanne. His research is focused on addressing the most important limitations of CAR T-cell therapy, including specificity, potency and manufacturing hurdles.
ADVISOR_Bernhard_Gentner
Prof. Bernhard GENTNER
Bernhard is an associate professor of Immuno-Oncology at the Department of Oncology of the University of Lausanne Hospital (CHUV). He is attending physician and haematologist, specialist in haematologic stem cell transplantation and haematopoietic stem cell engineering. He is a Group leader, at the Translational stem cell and leukaemia Unit of Ospedale San Raffaele in Milan, Italy. Bernhard is also a scientific co-founder of Genenta Science, a Nasdaq-listed company focusing on the development of cell-based cancer immunotherapy.
ADVISOR_Dirk_Groenewegen
Dirk Groenewegen
Dirk is the founder, former CEO and Board Director of Glycostem Therapeutics, a Dutch company pioneering the development of NK and CAR-NK cell therapies for oncology applications. He is a Cell & Gene Therapy consultant and a business development expert supporting Life Science start-ups and early-stage companies.
Tigen_Uebele_Friedemann_01
Friedemann Übele
Friede is the Head Manufacturing Science & Technology at Tigen Pharma. He has gathered significant aseptic process development expertise during his time at Novartis, leading projects for automating and simplifying CGT manufacturing.

Board of directors

Luc_LIM4557
LUC HENRY
Founder and CEO
Luc graduated from the University of Oxford with a DPhil in Chemical Biology. He has 10 years of research experience and published over 15 peer-reviewed scientific reports in chemistry, biotechnology and immunology. Prior to founding Limula, he was a strategic advisor to the President of EPFL, Martin Vetterli. At Limula, his role is to build meaningful partnerships to maximise the impact of our technology.
Yann_LIM4514
Yann Pierson
Founder and CTO
Yann graduated from EPFL with a PhD in Chemical Biology and is a certified mechanical designer. He invented, patented and built the first prototype of the technology behind our revolutionary CGT manufacturing platform in his garage during the COVID pandemic lock-down. At Limula, his role is to build an innovative product that meets the performance, quality and regulatory needs of our customers.
Tom_LIM4471
Thomas Eaton
Founder and COO
Tom graduated from the University of Basel with a PhD in Material Sciences. Tom has extensive experience in project management, budget tracking, outsourcing and supplier oversight. He has worked for, and consulted to, multinationals, including Deloitte, UBS and SwissRe as a project facilitator. At Limula, his role is to establish company processes to support our objectives and reach our potential.
Pierre_DSC2362-scaled_V2
Pierre Morgon
Independent
Pierre is a seasoned board director. He holds a Doctorate of Pharmacy, a Master in Business Law and a MBA, as an alumnus of INSEAD and IMD. Pierre has over 35 years of experience in the global pharmaceutical and biological industry with direct experience of blockbuster products in diverse markets (primary care, specialty care, hospital, vaccines, and biotechnology).

CAREERS

Join us!

Our ambition is to grow our multidisciplinary team of engineers and biologists with a proactive approach to excellence and diversity.
If you want to contribute your passion and expertise to reaching our goals, we would love to hear from you!
Limula SA
Biopôle StartLab
CH–Lausanne
© 2023 Limula SA
Limula SA
Biopôle StartLab
CH–Lausanne
Privacy Policy
Imprint
© 2023 Limula SA